Related Experiment Video
Updated: Oct 11, 2025
08:05
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
Published on: June 10, 2025
754
['Intelligent case-finding' in prostate cancer: an alternative to population-based screening]
Theo M de Reijke1,2, Ivo G Schoots3, Kees van den Berg4
1Amsterdam UMC, locatie AMC, afd. Urologie, Amsterdam.
Nederlands Tijdschrift Voor Geneeskunde
|December 2, 2021
Summary
A proposed prostate cancer screening program in the Netherlands focuses on early detection of high-risk tumors using MRI. This approach aims to reduce prostate cancer mortality and healthcare costs.
Area of Science:
- Oncology
- Radiology
- Public Health
Background:
- Population-based prostate cancer screening was previously denied in the Netherlands.
- Advances in prostate MRI enable better detection of significant prostate cancer.
- Identification of high-risk groups is crucial for timely intervention.
Purpose of the Study:
- To propose a novel prostate cancer screening program.
- To identify and treat men with high-risk tumors at an earlier stage.
- To evaluate the program's impact on prostate cancer mortality and cost-effectiveness.
Main Methods:
- Utilizing prostate Magnetic Resonance Imaging (MRI) for tumor detection.
- Stratifying patients into risk groups based on imaging and clinical data.
- Implementing early treatment protocols for identified high-risk individuals.
Main Results:
- (Study pending results) Focus on early detection of aggressive prostate cancer.
- (Study pending results) Potential for improved patient outcomes through timely intervention.
- (Study pending results) Assessment of cost-effectiveness compared to standard care.
Conclusions:
- Early detection of high-risk prostate cancer via MRI may improve outcomes.
- A targeted screening program could reduce prostate cancer mortality.
- Further evaluation is needed to confirm cost-effectiveness.
